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Abstract
Previous in vitro studies have shown that the Ca2-regulated S100B protein modulates the assembly-disassembly of
microtubules (MTs) and type III intermediate filaments (IFs). In the present report, by double immunofluorescence
cytochemistry S100B was localized to both GFAP/vimentin IFs and MTs as well as to centrosomes in U251 glial cells. In cells
treated with the MT-depolymerizing agent, colchicine, S100B remained associated with the rearranged GFAP IFs
throughout the cell and, at the cell periphery, vimentin IFs. In cells treated with the MT stabilizing agent, taxol, S100B
followed partly the rearrangement of MTs and partly the rearrangement of IFs. Under the latter condition, bundles of MTs
with their associated S100B appeared surrounded and/or flanked by rearranged IFs with their associated S100B.
Colocalization of S100B with closely arranged IFs and MTs was best evident in cells manipulated with taxol and in triton-
cytoskeletons. In these cases, MTs and their associated S100B appeared surrounded and/or flanked by and/or intermingled
with IFs and their associated S100B. Also, a preferential association of S100B with GFAP vs. vimentin IFs could be observed
near the nucleus where colocalization of S100B with MTs was also maximal. Condensation of IFs and alteration of the MT
network caused by treatment of cells with the phosphatase inhibitor, okadaic acid, resulted in a concomitant condensation/
alteration of the S100B immunoreactivity. The present results lend support to the possibility that S100B may be an important
factor implicated in the regulation of the dynamics of MTs and IFs. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
S100B, formerly known as S100L, is a member of a
multigenic family of Ca2-binding proteins of the
EF-hand type which have been implicated in Ca2
signal transduction (for reviews see [1^3]). S100B is
expressed in a large variety of cell types and is abun-
dant in glial cells where it has been localized to the
cytoplasm, plasma membranes and intracellular
membranes, as well as to cytoskeleton constituents
[4^9]. S100B has been implicated in the regulation
of several intracellular activities [1^3]. Inhibition of
microtubule (MT) assembly and stimulation of MT
disassembly ([10], and Refs. therein), stimulation of a
brain aldolase activity [11], a phosphoglucomutase
activity [12] and a membrane-bound guanylate cy-
clase activity [13,14], and inhibition of the phosphor-
ylation of a number of substrate (e.g. MARCKS,
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d proteins, caldesmon, GAP-43, neurogranin, MyoD,
p53, and annexin II) [1^3] are among the intracellu-
lar activities attributed to S100B. Also, inhibition of
S100B synthesis in a glial cell line by means of anti-
sense oligonucleotides resulted in a more organized
micro¢lament network, suggesting the possibility
that S100B might be implicated in the control of
the state of assembly of micro¢laments [15].
Recently, we reported that S100B and S100A1 in-
hibit the assembly of glial ¢brillary acidic protein
(GFAP), the subunit of type III intermediate ¢la-
ments (IFs) speci¢c to glial cells, and desmin, the
type II IF subunit speci¢c to muscle cells, and pro-
motes GFAP and desmin IF disassembly in a Ca2-
dependent manner by binding stoichiometrically and
with a high a⁄nity to and sequestering unassembled
GFAP and desmin, respectively [16^18]. We also
identi¢ed the putative S100B- and S100A1-binding
site on GFAP and desmin as a stretch of residues
in the GFAP and desmin N-terminal domain
[19,20] that harbors the so-called RP-box motif, a
sequence critical to GFAP and desmin assembly
into ¢laments [21]. All these data suggest that
S100B in glial cells and S100A1 in muscle cells might
play a role in the regulation of IF dynamics.
In spite of the above biochemical evidence, little is
known about the S100B-type III IF and S100B-MT
interactions in glial cells. As mentioned above, cir-
cumstantial evidence indicates that S100B associates
with IFs in cultured Schwann cells and MT struc-
tures [4^9]. We addressed the functional relationships
between S100B and IFs and MTs in vivo by analyz-
ing the distribution of S100B in a glial cell line under
various experimental conditions. Our results indicate
that: (1) S100B is distributed into at least two pools,
one associated with IFs, and a second one associated
with the centrosomes and MTs; (2) S100B associates
with GFAP IFs throughout the cell and with vimen-
tin IFs at the cell periphery; (3) the fraction of
S100B that is associated with glial IFs follows the
IF rearrangement induced by colchicine and the frac-
tion of MT-associated S100B follows the MT rear-
rangement induced by taxol while maintaining its
association with IFs; and (4) treatment of cells
with the phosphatase inhibitor, okadaic acid, causes
depolymerization of both IFs and MTs with con-
comitant and coincident redistribution of S100B.
The present data add to the possibility that S100B
may have a role in the regulation of the state of
assembly of both IFs and MTs in vivo.
2. Materials and methods
2.1. Materials
U251 MG-NIH glioma cells were a generous gift
from Dr. S.L. Hubbard (Toronto, Ontario, Canada).
The monoclonal anti-S100B antibody (clone SH-B1),
monoclonal anti-K-tubulin antibody (clone DM1A),
Cy3-conjugated monoclonal anti-L-tubulin antibody
(clone TUB 2.1), Cy3-conjugated monoclonal anti-
vimentin antibody (clone V9), £uorescein-conjugated
goat anti-mouse IgG, rhodamine-conjugated goat
anti-rabbit IgG colchicine, taxol, p-phenylenediamine
were from Sigma (Milan, Italy); monoclonal anti-vi-
mentin antibody (clone V9) from Boehringer (Mann-
heim, Germany); polyclonal anti-S100B antiserum
from SWant (Bellinzona, Switzerland); polyclonal
anti-GFAP antiserum from Dakopatts (Denmark).
MEM K-medium, fetal bovine serum, and normal
mouse serum were from Gibco BRL (Life Technol-
ogies, Paisley, UK). All other reagents were analyt-
ical grade reagents.
2.2. Cell culture and immuno£uorescence analyses
U251 glial cells were cultured in K-MEM with L-
glutamine supplemented with 10% (v/v) FBS, 100 U/
ml penicillin, and 100 Wg/ml streptomycin, in a H2O-
C
Fig. 1. S100B is colocalized with IFs in U251 MG-NIH glioma cells. By double immuno£uorescence, a monoclonal anti-S100B anti-
body (A,C,G) decorates GFAP IFs (B,D,H) in control cells (A,B), cells cultivated for 3 days in the absence of serum (C,D), and cells
treated with colchicine (G,H). Note that colchicine treatment causes bundling and collapse of IFs (H) and that S100B colocalizes with
bundles and collapsed IFs (G). Cells cultivated in the absence of serum are characterized by long processes (C,D). Note the mosaic
expression of GFAP (D) in contrast to the expression of S100B in nearly all cells (C). S100B (E) is also colocalized with vimentin IFs
(F), but colocalization is more evident at the cell periphery. Near the nucleus (asterisk), the S100B-decorated IFs (likely GFAP IFs
and/or MTs ^ see below) are found on a di¡erent focus plane with respect to vimentin IFs. Bar = 5 Wm.
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saturated 5% CO2 atmosphere at 37‡C. U251 glial
cells were plated on glass coverslips (13 mm in diam-
eter) in 24-multiwell plates. Cells were seeded at
3U104 cells/well and cultured for 24 h. In some ex-
periments, cells were grown in the presence of serum
for 24 h followed by a 3 day incubation in the ab-
sence of serum. After washings with phosphate buf-
fered saline (PBS), cells on coverslips were ¢xed with
methanol at 320‡C for 7 min, rinsed in PBS, treated
with 0.1% (v/v) Triton X-100 in PBS for 5 min at
room temperature, and rinsed in PBS. Non-speci¢c
binding of antibodies or antisera was blocked by a
preliminary incubation of ¢xed cells with 3% (w/v)
bovine serum albumin (BSA) and 1% (w/v) glycine in
PBS. This was followed by an incubation at room
temperature for 1 h with the appropriate primary
antibody diluted in 3% (w/v) BSA in PBS. Dilutions
of primary antibodies were as follows: monoclonal
anti-S100B, 1/20; monoclonal anti-vimentin, 1/4;
polyclonal anti-S100B antiserum, 1/20; monoclonal
anti-K-tubulin antibody, 1/40; polyclonal anti-
GFAP antiserum, 1/200; Cy3-conjugated monoclo-
nal anti-L-tubulin antibody, 1/100; Cy3-conjugated
monoclonal anti-vimentin antibody, 1/4000. After
washings for a total of 20 min with 0.1% (v/v)
Tween-20 in PBS, the appropriate secondary anti-
body (diluted 1/50 in 3% (w/v) BSA in PBS) was
applied at room temperature for 1 h. For double
indirect/indirect immunostaining the two above incu-
bations were performed in sequence. For double in-
direct/direct immunostaining the primary and secon-
dary antibodies were used in sequence as described
above, then cells were sequentially incubated for 1 h
with 10% normal mouse serum in 3% (w/v) BSA in
PBS and the appropriate Cy3-conjugated monoclo-
nal antibody for 1 h at room temperature. The cover-
slips were then rinsed with 0.1% (v/v) Tween-20 in
PBS for a total of 20 min, air dried and mounted on
microscope slides in 80% (v/v) glycerol, 1 mg/ml
p-phenylenediamine as an antifading agent, 0.02%
(w/v) NaN3, in PBS. In control experiments, the
primary anti-S100B antiserum was either omitted
or preabsorbed with the S100B before use. Cells
were viewed in a Leica DM RB £uorescence micro-
scope using an oil-immersion 100U objective and
photographed on a Kodak TMax 400 or TMax
3200 ¢lm.
For drug treatment of glial cells, colchicine (¢nal
concentration 10 Wg/ml) was added to the medium
for 20 h; taxol in dimethylsulfoxide was added to the
medium to a ¢nal concentration of 10 WM and the
cells were cultivated for an additional 24 h; okadaic
acid was added to the medium to a ¢nal concentra-
tion of 1 WM and the cells were cultivated for an
additional 30 min. Subsequent steps were as de-
scribed above.
To obtain triton-cytoskeletons containing MTs,
cells were extracted at 37‡C for 30^40 s with 80
mM Pipes, pH 6.8, 0.1 M KCl, 1 mM MgCl2,
1 mM EGTA, 10% (w/v) glycerol, 0.5% (v/v) Triton
X-100, and washed twice with the same bu¡er with-
out Triton X-100 before ¢xation as above.
3. Results
3.1. S100B is associated with GFAP/vimentin IFs in
U251 glial cells
By double immuno£uorescence performed with a
monoclonal anti-S100B antibody (Fig. 1A) and a
polyclonal anti-GFAP antiserum (Fig. 1B), the
S100B immunoreactivity in U251 glial cells was
found in the form of a ¢lamentous network that
was nearly superimposed to that of the GFAP IF
network. Whereas most, if not all cells were S100B-
C
Fig. 2. S100B is colocalized with MTs in U251 MG-NIH glioma cells. By double immuno£uorescence, a polyclonal anti-S100B antise-
rum (A) binds to a paranuclear structure (asterisks) that is found on a di¡erent focus plane with respect to vimentin IFs (B). This
structure appears £anked and/or surrounded by vimentin IFs (B). This antiserum also binds to vimentin IF-associated S100B in cell
processes (arrow). The above paranuclear structure is made of MTs as it can be labeled by a monoclonal anti-K-tubulin antibody (D)
with which S100B is associated (C). By double, indirect/direct immuno£uorescence, the monoclonal anti-S100B antibody (E) also deco-
rates MTs (labeled by a monoclonal Cy3-conjugated anti-L-tubulin antibody) (F) near the nucleus and, to some extent, in the cell pe-
riphery (arrows). Extensive colocalization of GFAP IFs (G) and MTs (H) can be observed in a paranuclear position, as investigated
by double immuno£uorescence with a polyclonal anti-GFAP antiserum and a monoclonal anti-K-tubulin antibody. Note the mosaic
distribution of GFAP. Bar = 5 Wm.
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positive, some cells did not express GFAP (not
shown, but see below). In these cells the monoclonal
anti-S100B antibody decorated a ¢lamentous net-
work as well. Mosaic expression of GFAP in glial
cell lines was reported [22]. In U251 cells cultivated
for 1 day in the presence of serum and for the next
2^3 days in the absence of serum (a condition in
which cells proliferated at a reduced rate and were
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characterized by long extensions), again the S100B
immunoreactivity was in the form of a ¢lamentous
network (Fig. 1C) nearly superimposed to the GFAP
IF network (Fig. 1D). Again some cells were GFAP-
negative with persistence of the S100B immunoreac-
tivity in the form of a ¢lamentous network. These
data suggest that a fraction of S100B may be asso-
ciated with GFAP and, eventually, vimentin IFs (see
below) in vivo. By double, indirect/direct immuno-
£uorescence with the monoclonal anti-S100B anti-
body and a monoclonal anti-vimentin antibody, co-
localization of S100B with vimentin IFs could also
be observed at the cell periphery (Fig. 1E,F). Near
the nucleus a relatively large area that was rich in
GFAP IFs and their associated S100B (Fig. 1B) ap-
peared to contain vimentin IFs on a di¡erent focus
plane (compare Fig. 1E with Fig. 1F), suggesting a
preferential association of S100B with GFAP rather
than vimentin IFs in discrete parts of the cell.
To validate the conclusion that in U251 glial cells
S100B is associated with GFAP and, at the cell pe-
riphery, vimentin IFs, cells were cultivated in the
presence of colchicine (10 Wg/ml) for 1 day before
immunocytochemistry. It is known that MT depoly-
merization caused by colchicine results in a reorgan-
ization (bundling) and collapse of type III IFs
around the nucleus [23,24]. Fig. 1G shows that in
colchicine-treated cells the S100B immunoreactivity
followed the destiny of the GFAP IF network (Fig.
1H), in agreement with the conclusion that a fraction
of S100B may be associated with GFAP IFs in glial
cells. In similar experiments performed with the anti-
S100B monoclonal antibody and the anti-vimentin
monoclonal antibody again association of S100B
with vimentin IFs was best evident at the cell periph-
ery (not shown). A polyclonal anti-S100B antiserum
[25] also decorated bundles of collapsed IFs in cells
treated with colchicine (not shown). In U251 glial
cells treated with Triton X-100 plus a high KCl con-
centration, a condition in which the IF network is
being preserved whereas MTs and micro¢laments
are being extracted [26], the S100B recognized
by the monoclonal antibody was still associated
with the GFAP/vimentin IF immunoreactivity (not
shown).
3.2. S100B is associated with MTs in glial cells
A polyclonal anti-S100B antiserum [25] was also
tested in double immuno£uorescence experiments
with a monoclonal anti-GFAP antibody (not
shown), a monoclonal anti-vimentin antibody (Fig.
2A,B), or a monoclonal anti-tubulin antibody (Fig.
2C^F). The polyclonal anti-S100B antiserum, that
decorated IFs in cell processes (Fig. 2A,B), appeared
to bind mostly to an organized cell structure that was
located on one side of the nucleus and/or running
parallel to the long axis of the cell (Fig. 2A,B).
This structure did not appear to consist of vimentin
IFs since it was not decorated by the anti-vimentin
antibody (Fig. 2B). Rather, this structure appeared
surrounded and/or £anked by vimentin IFs, as could
be observed by changing the focus plane. By con-
trast, the same structure appeared to contain
GFAP IFs (see Fig. 2G,H). The S100B-positive, par-
anuclear structure decorated by the polyclonal anti-
S100B antiserum (Fig. 2C,E) was also decorated by
the anti-tubulin antibody (Fig. 2D,F). The paranu-
clear region rich in GFAP IFs, MTs, and their asso-
ciated S100B also contained Golgi membranes which
were detected using £uorescein-labeled wheat germ
agglutinin (not shown). Golgi membranes could be
decorated by the polyclonal anti-S100B antiserum
(not shown, but see [6]). Experiments performed
with the monoclonal anti-S100B antibody and the
monoclonal anti-tubulin antibody, and with the
C
Fig. 3. Association of S100B with cytoplasmic, spindle and aster MTs, the centrosomes and the center part of the midbody in U251
MG-NIH glioma cells. Cells were double immunostained using the anti-S100B polyclonal antiserum (A,C,E,G,I,K,M,O) and the
monoclonal anti-K-tubulin antibody (B,D,F,H,J,L,N,P). Intact cells (A^J) and triton-cytoskeletons (K^P) obtained under conditions
that preserve MTs (see Section 2) were used in these experiments. S100B is found associated with the centrosomes (B,D,F) (arrows) in
both interphase cells (A,B) and dividing cells (C^F). In prophase cells (C) S100B is also found di¡usely around the nucleus. A simi-
larly di¡use S100B staining can be seen in metaphase cells (E). In anaphase cells (G,H) S100B is found around separated chromo-
somes (G) where MTs are also found (H). Association of S100B with cytoplasmic MTs (K,L), spindle MTs (M,N) and aster MTs
(O,P) is best evident in triton-cytoskeletons, suggesting that binding of the polyclonal anti-S100B antiserum to soluble and membrane-
bound S100B in intact cells obscures detection of cytoskeleton-associated S100B. Bar = 5 Wm.
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monoclonal anti-tubulin antibody and the polyclonal
anti-GFAP antiserum con¢rmed that near the nu-
cleus and/or on one side of the nucleus S100B was
colocalized with both, MTs and GFAP IFs (Fig. 2E^
H). These experiments also showed that colocaliza-
tion of S100B, as detected by the monoclonal anti-
S100B antibody, with both GFAP IFs and MTs was
most intense near the nucleus (Figs. 1A^D and 2).
Away from this region, colocalization of MTs and
S100B could also be detected at discrete cell sites
(Fig. 2E,F, arrows). Fig. 2G,H shows extensive co-
localization of MTs and GFAP IFs, particularly near
the nucleus, i.e. in a region also rich in S100B as
outlined above.
S100B, as detected using the anti-S100B polyclonal
antiserum, was localized to centrosomes in both in-
terphase (Fig. 3A,B) and dividing cells. In prophase
cells (Fig. 3C,D), the polyclonal anti-S100B antise-
rum decorated the centrosomes and perinuclear
structures. In metaphase cells, this antiserum deco-
rated the centrosomes and a material associated with
the mitotic spindle (Fig. 3E,F). In anaphase cells,
S100B was detected in a pericentrosomal position
and, to a larger extent, an equatorial position (Fig.
3G,H). In telophase cells, S100B was found all
around the separated chromosomes and in the center
part of the midbody (Fig. 3I,J).
Extraction of membranes and cytoplasmic proteins
with Triton X-100 under conditions preserving MTs
resulted in a clearer resolution of MT-associated
S00B. The polyclonal anti-S100B antiserum distinctly
decorated cytoplasmic MTs, in addition to perinu-
clear material containing tubulin, and spindle and
aster MTs (Fig. 3K^P). By double immuno£uores-
cence using the monoclonal anti-S100B antibody
and the polyclonal anti-S100B antiserum, ¢lamen-
tous structures that were decorated by both antibod-
ies were found to co-exist in the same cell along with
¢lamentous structures preferentially decorated by in-
dividual antibodies (not shown).
To support the conclusion that S100B associates
with both IFs and MTs, U251 cells were treated with
the MT stabilizing drug, taxol, before immunocyto-
chemistry. Under these conditions, the GFAP IF net-
work appeared dramatically rearranged (Fig. 4B), as
was the GFAP IF-associated S100B immunoreactiv-
ity detected by the monoclonal anti-S100B antibody
(Fig. 4A). Taxol treatment caused the formation of
bundles of MTs that were decorated by the polyclo-
nal anti-S100B antiserum (Fig. 4C,D). In addition,
the polyclonal anti-S100B antiserum also detected
S100B between fragmented nuclear material (Fig.
4C). Here, S100B likely is associated with fragmented
Golgi membranes, as suggested by coincident label-
ing of these structures by £uorescein-conjugated
wheat germ agglutinin (not shown). As mentioned
above, S100B is also found associated with the Golgi
complex [6]. Also, in several instances the MTs bun-
dles appeared surrounded and/or £anked by rear-
ranged IFs. This was directly seen in experiments
in which taxol-treated cells were reacted with the
monoclonal anti-tubulin antibody and the anti-
GFAP antiserum (not shown) and indirectly con-
cluded by experiments performed with the monoclo-
nal anti-S100B antibody and the polyclonal anti-
S100B antiserum (Fig. 4E and F, respectively) as
well as by experiments performed with the polyclonal
anti-S100B antiserum (Fig. 4G,I) and the monoclo-
nal anti-vimentin antibody (Fig. 4H,J). In these
cases, the MT bundles and their associated S100B
appeared surrounded and/or £anked by IFs and their
associated S100B. An unrelated polyclonal antiserum
6
Fig. 4. Double immuno£uorescence analyses of S100B, tubulin, GFAP, and vimentin in U251 MG-NIH glioma cells grown in the
presence of serum containing 10 WM taxol. Taxol causes a coincident rearrangement of S100B (A) and GFAP IFs (B) in cells express-
ing both proteins. S100B was detected with a monoclonal antibody and GFAP with a polyclonal antiserum (A,B). Taxol-induced bun-
dles of MTs, detected with a monoclonal anti-K-tubulin antibody (arrows in D), are also S100B immunoreactive (arrows in C). The
S100B immunoreactivity in C was detected with a polyclonal anti-S100B antiserum. Use of a monoclonal anti-S100B antibody (which
binds to IF-associated S100B) (E) and a polyclonal anti-S100B antiserum (which binds to MT-associated S100B) (F) allows detection
of partial colocalization of IFs and MTs in taxol-treated cells (arrows). Similar images can be obtained using a polyclonal anti-S100B
antiserum (G) and a monoclonal anti-vimentin antibody (H). In several instances MT bundles (and their associated S100B) are
£anked and/or surrounded by IFs (and their associated S100B) (arrows in I and J, that show a ¢eld in G and H, respectively, at a
higher magni¢cation). Bar = 5 Wm.
BBAMCR 14402 4-12-98
G. Sorci et al. / Biochimica et Biophysica Acta 1448 (1998) 277^289 285
(anti-PGP 9.5) and a non-immune serum did not
stain MTs or IFs in control or taxol-treated cells
(not shown).
Treatment of cells with vinblastine, another MT-
perturbing agent, resulted in collapsing of bundled
IFs and their associated S100B (which was detected
by both the monoclonal antibody and the polyclonal
antiserum), and formation of typical MT paracrys-
Fig. 5. Double immuno£uorescence localization of S100B, tubulin, vimentin, and GFAP in okadaic acid-treated U251 MG-NIH glio-
ma cells. Treatment of cells with the phosphatase inhibitor, okadaic acid, causes extensive disassembly of GFAP IFs (detected with a
polyclonal anti-GFAP antiserum) and their condensation in a paranuclear position (B) likely due to GFAP hyperphosphorylation (see
text). Under these conditions, S100B (detected with a monoclonal anti-S100B antibody) follows the GFAP IF rearrangement (A).
Double, indirect/direct immuno£uorescence performed with a monoclonal anti-S100B antibody (C) and a Cy3-conjugated vimentin
monoclonal antibody (D) shows that vimentin IFs appear much less perturbed by okadaic acid treatment (compare D with B), where-
as IF-associated S100B condensates in a paranuclear structure (asterisks in C) composed of GFAP IFs (see B) and/or MTs (see be-
low). Again, note that the S100B-positive paranuclear structure (asterisks in C) is found on a di¡erent focus plane as compared with
vimentin IFs (asterisks in D). MTs, detected with a monoclonal anti-K-tubulin antibody (F), also appear disassembled and/or con-
densed after okadaic acid treatment, and S100B, detected with a polyclonal anti-S100B antiserum, remains colocalized with these MTs
under these conditions (E). Bar = 5 Wm.
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tals which were not decorated by either anti-S100B
antibody, but appeared surrounded by S100B (not
shown).
3.3. E¡ects of okadaic acid on the distribution of
S100B in U251 glial cells
The number and topographical distribution of IFs
as well as their dynamics are regulated by phosphor-
ylation of IFs and their unassembled subunits [27^
29]. Accordingly, serine/threonine protein phospha-
tases are important in maintaining cytoskeletal integ-
rity [30,31]. The phosphatase inhibitor, okadaic acid
[32,33], caused disassembly of GFAP IFs and GFAP
IF condensation in a paranuclear position in U251
glial cells (Fig. 5B) likely due to hyperphosphoryla-
tion of GFAP, with concomitant and coincident con-
densation of its associated S100B (Fig. 5A), whereas
vimentin IFs appeared less sensitive to okadaic acid
under the same conditions (Fig. 5D). Again, the peri-
nuclear vimentin IF network was not coincident with
the GFAP condensed material and its associated
S100B (Fig. 5C). MTs also appeared perturbed by
okadaic acid treatment, in that they appeared depo-
lymerized to a remarkable extent (Fig. 5F). It is
known that phosphorylation of MT-associated pro-
teins results in disassembly of MTs and inhibition of
MT formation [34,35]; thus, okadaic acid treatment
might have resulted in hyperphosphorylation of MT-
associated proteins. The paranuclear structure that
was intensely decorated by the polyclonal anti-
GFAP antiserum and the monoclonal anti-S100B
antibody (Figs. 1^3) was also decorated by the
monoclonal anti-tubulin antibody and the polyclonal
anti-S100B antiserum under these conditions (Fig.
5E,F).
4. Discussion
The present data indicate that in U251 glial cells
S100B is associated with at least two cytoskeleton
constituents, i.e. GFAP IFs throughout the cell
and/or vimentin IFs in the cell periphery, and MTs,
including those found in asters and mitotic spindles,
the centrosomes, and, in telophase cells, the center
part of the midbody. Speci¢cally, a fraction of S100B
is found associated with GFAP/vimentin IFs and
follows the rearrangements of IFs induced by colchi-
cine, taxol, or okadaic acid treatment of glial cells.
Another fraction of S100B is found associated with
the centrosomes, the center part of the midbody in
mitotic cells, and MTs, and follows the rearrange-
ment of MTs induced by taxol or okadaic acid.
The monoclonal anti-S100B antibody and the poly-
clonal anti-S100B antiserum used in the present
study (which are commercially available) proved spe-
ci¢c to S100B by Western blotting (not shown) and
failed to decorate cell structures once preabsorbed
with pure S100B, whereas it maintained its S100B-
binding properties unaltered following preabsorption
with pure S100A1 (not shown). The polyclonal anti-
S100B antiserum was characterized in previous stud-
ies and found to be speci¢c to S100B [25]. On the
basis of the present ¢ndings we suppose that the
monoclonal anti-S100B antibody mostly recognizes
an epitope of IF-associated and, to some extent,
MT-associated S100B. This epitope is less distinctly
recognized by the polyclonal anti-S100B antiserum in
intact cells, probably because of binding of this anti-
serum to a fraction of S100B that is associated with
intracellular membranes [4,6,36]. In fact, the polyclo-
nal anti-S100B antiserum decorates IFs in cells ex-
tracted with Triton X-100 plus high KCl and in cells
treated with colchicine or vinblastine (not shown),
decorates cytoplasmic and spindle and aster MTs in
triton-cytoskeletons (Fig. 3K^P), and distinctly dec-
orates bundles of MTs in taxol-treated cells (Fig.
4C,D). These observations suggest that in intact cells
binding of the polyclonal antiserum to soluble and/or
membrane-associated S100B obscures visualization
of IF- and MT-associated S100B. In fact, solubiliza-
tion of membranes with Triton X-100 under con-
ditions that preserve MTs allowed detection of
MT-associated S100B as investigated by means of
the polyclonal anti-S100B antiserum (Fig. 3K^P).
By double immuno£uorescence, the MTs deco-
rated by the polyclonal anti-S100B antiserum appear
surrounded and/or £anked by vimentin IFs and in-
termingled with GFAP IFs and their associated
S100B, in both control and taxol-treated cells as
well as in triton-cytoskeletons. Together with pre-
vious data documenting regulatory e¡ects of S100B
on the dynamics of both GFAP IFs and MTs in
vitro [10,16], the present results strongly suggest
that S100B may be positioned along and/or in close
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proximity of IFs and MTs to take part in the regu-
lation of their assembly state and/or to target some
S100B ligands to discrete cell sites.
The presence of S100B on or close to the centro-
somes, and the center part of the midbody appears
interesting in light of the role of these structures as
MT nucleation centers. Although S100B interferes
with both the nucleation and the elongation of
MTs in the presence of a few micromolar levels of
free Ca2 in vitro [10], its main e¡ect consists of a
retardation of the onset of MT formation, a decrease
in the MT number concentration, and an increase in
the mean MT length at pH 6.7, whereas an addition-
al and marked, inhibitory e¡ect on MT elongation
can be seen at pH 7.2^7.4 [10]. The present identi¢-
cation of S100B on the centrosomes in both inter-
phase and dividing cells and the center part of the
midbody lends support to the possibility that S100B
might play a role in the regulation of MT formation
by acting at physiological sites of MT nucleation,
where S100B might avoid excess tubulin polymeriza-
tion. In this respect, it is important to note that
S100B interacts with phosphocellulose-puri¢ed tubu-
lin and inhibits puri¢ed tubulin polymerization in
vitro [10,37]. In addition to its potential role as a
regulator of MT formation, S100B might contribute
to the rapid disassembly of MTs occurring at the
onset of mitosis. In vitro, S100B causes a rapid and
almost complete disassembly of preformed MTs in a
Ca2- and pH-dependent manner, with lower Ca2
concentrations needed with increasing pH values
[10,38]. S100B might thus be one of the factors
postulated to increase the Ca2 sensitivity of poly-
merized tubulin at the onset of mitosis ([39], and
Refs. therein).
The present data give evidence for the ¢rst time for
structural relationships between S100B and two main
cytoskeleton constituents, IFs and MTs, in a cell
model system. Future studies should de¢ne the func-
tional meaning of the association of S100B with IFs
and MTs and the relationship between this associa-
tion and transduction of the Ca2 signal.
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